Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Meisel

Showing results (281-290 of 311) with videos related to

Pageof 32
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized studyBaltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Journal of Neuroinflammation|April 13, 2022
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patientsChristopher Nelke, Frauke Stascheit, Carmen Eckert, et al.
The Lancet. Neurology|July 17, 2023
The structured ambulatory post-stroke care program for outpatient aftercare in patients with ischaemic stroke in Germany (SANO): an open-label, cluster-randomised controlled trialChristopher J Schwarzbach, Felizitas Anna Eichner, Viktoria Rücker, et al.
European Stroke Journal|March 28, 2022
Preventive antibiotic therapy in acute stroke patients: A systematic review and meta-analysis of individual patient data of randomized controlled trialsWilleke F Westendorp, Jan-Dirk Vermeij, Craig J Smith, et al.
Orphanet Journal of Rare Diseases|March 12, 2025
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable dataAbderhmane Slioui, Giulia Tammam, Fiammetta Vanoli, et al.
Neurology|December 6, 2019
Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 casesBernhard Neumann, Klemens Angstwurm, Philipp Mergenthaler, et al.
Journal of Neurology|September 27, 2022
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravisFrauke Stascheit, Ulrike Grittner, Sarah Hoffmann, et al.
Brain : a Journal of Neurology|August 21, 2016
Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesisJakob Kreye, Nina K Wenke, Mariya Chayka, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 4, 2008
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAEMarloes van Zwam, Ruth Huizinga, Marie-José Melief, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 5, 2022
Eculizumab versus rituximab in generalised myasthenia gravisChristopher Nelke, Christina B Schroeter, Frauke Stascheit, et al.
Pageof 32

Showing results (281-290 of 311) with videos related to

Sort By:
Pageof 32
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized studyBaltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Journal of Neuroinflammation|April 13, 2022
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patientsChristopher Nelke, Frauke Stascheit, Carmen Eckert, et al.
The Lancet. Neurology|July 17, 2023
The structured ambulatory post-stroke care program for outpatient aftercare in patients with ischaemic stroke in Germany (SANO): an open-label, cluster-randomised controlled trialChristopher J Schwarzbach, Felizitas Anna Eichner, Viktoria Rücker, et al.
European Stroke Journal|March 28, 2022
Preventive antibiotic therapy in acute stroke patients: A systematic review and meta-analysis of individual patient data of randomized controlled trialsWilleke F Westendorp, Jan-Dirk Vermeij, Craig J Smith, et al.
Orphanet Journal of Rare Diseases|March 12, 2025
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable dataAbderhmane Slioui, Giulia Tammam, Fiammetta Vanoli, et al.
Neurology|December 6, 2019
Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 casesBernhard Neumann, Klemens Angstwurm, Philipp Mergenthaler, et al.
Journal of Neurology|September 27, 2022
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravisFrauke Stascheit, Ulrike Grittner, Sarah Hoffmann, et al.
Brain : a Journal of Neurology|August 21, 2016
Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesisJakob Kreye, Nina K Wenke, Mariya Chayka, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 4, 2008
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAEMarloes van Zwam, Ruth Huizinga, Marie-José Melief, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 5, 2022
Eculizumab versus rituximab in generalised myasthenia gravisChristopher Nelke, Christina B Schroeter, Frauke Stascheit, et al.
Pageof 32